ilaris poudre pour solution
novartis pharmaceuticals canada inc - canakinumab - poudre pour solution - 150mg - canakinumab 150mg - immunosuppressive agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents